S. St, E. Ls, K. D. , P. De, S. M. et al., Perspectives on Cancer Therapy-Induced Mucosal Injury: pathogenesis, measurement, epidemiology, and consequences for patients, Cancer, vol.100, pp.1995-2025, 2004.

B. La, E. Jb, R. , M. P. , and F. Hj, Patient reports of complications of bone marrow transplantation, Support Care Cancer, vol.8, pp.33-39, 2000.

R. , B. La, and E. Jb, Complications of radiation therapy for head and neck cancers: the patient's perspective, Cancer Nurs, vol.25, pp.461-467, 2002.

S. St, The Pathobiology of mucositis, Nat Rev Cancer, vol.4, pp.277-284, 2004.

Q. B. , P. Cmj, B. Stone-r, F. M. Nma, and M. A. , Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients, European Journal of Cancer, vol.44, pp.61-72, 2008.

S. St, E. Jp, L. Epstein-jb, L. Fg, M. Wh et al., Validation of a New Scoring System for the Assessment of Clinical Trial Research of Oral Mucositis Induced by Radiation or Chemotherapy, Cancer, vol.85, pp.2103-2113, 1999.

S. Mm, W. Be, L. Me, C. Donaldson-g, and . Mk, Clinical assessment scale for the rating of the oral mucosal changes associated with bone marrow transplantation: development of an oral mucositis index, Cancer, vol.69, pp.2469-2477, 1992.

K. Wj, H. M. , W. C. , and Z. Cc, Oral mucositis complicating chemotherapy and/or radiotherapy: option for prevention and treatment, CA Cancer J Clin, vol.51, pp.290-315, 2001.

P. De, Research advances in oral mucositis, Curr Opin Oncol, vol.11, pp.261-266, 1999.

B. N. , S. M. Bacon-p, D. Addio-a, H. E. , and M. J. , Prospective oral mucositis in patients receiving high dose Melphalan or BEAM conditionning chemotherapy ? European Blood and Marrow Transplantation Mucositis Advisory Group, J Clin Oncol, vol.26, pp.1519-1525, 2008.

D. M. Hillier-kolarov-v, B. A. , and J. L. , Mucositis prevention by improved dental care in acute leukemia patients, Support Care Cancer, vol.14, pp.137-146, 2006.

R. K. Schubert-mm, C. T. , B. J. , S. R. , and Y. Y. , Methylenetetrahydrolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation, Bone Marrow Transplant, vol.37, pp.799-800, 2006.

B. A. and P. De, Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions, Oral Oncology, vol.39, pp.91-100, 2003.

S. St, S. Al, and L. A. , Oral complications in patients receiving treatment for malignancies other than of the head and neck, J Am Dent Assoc, vol.97, pp.468-472, 1978.

G. Mccarthy, A. Jd, G. H. , V. M. , and K. Wi, Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil, Oral Oncology, vol.34, issue.6, pp.484-490, 1998.
DOI : 10.1016/S1368-8375(98)00068-2

C. Ba, O. B. Sullivan, B. S. Donaldson-g, C. Cr, and S. Dd, Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation, Pain, vol.72, pp.333-346, 1997.

P. De, New Strategies for Management of Oral Mucositis in Cancer Patients, J Support Oncol, vol.4, pp.9-13, 2006.

S. Mccann, S. M. Bacon-p, E. H. , D. Addio-a, and M. J. , The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT, Bone Marrow Transplantation, vol.67, issue.2, pp.141-147, 2009.
DOI : 10.1002/cncr.22484

E. Ls, B. Bh, and K. Bh, Septicemia and shock syndrome due to viridians streptococci: a case control study of predisposing factors, Clin Infect Dis, vol.14, pp.1201-1207, 1992.

E. Ls, C. C. , C. M. , C. Sb, M. E. et al., The Burdens of Cancer Therapy, Clinical and Economic Outcomes of Chemotherapy ?Induced Mucositis, Cancer, vol.98, pp.1531-1539, 2003.

S. St, O. G. , F. H. , B. L. , B. Wz et al., Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation, J Clin Oncol, vol.19, pp.2201-2205, 2001.

W. Hv, C. Je, and E. Tob, Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane database of systematic reviews, 2007.

C. Je, W. Hv, F. S. Mccabe, M. , K. T. et al., Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane database of systematic reviews, 2010.

M. Jm, Les soins dentaires chez l'enfant atteint de leucémie, Inf Dent, vol.1, pp.23-28, 1998.

D. Bt, D. Kl, and J. J. , Educational issues in oral care, Semin Oncol Nurs, vol.20, pp.48-52, 2004.

R. Eb, P. De, S. M. , K. D. Mcguire, D. et al., Clinical Practice Guidelines for the Prevention and Treatment of Cancer Therapy-Induced Oral and Gastrointestinal Mucositis, Cancer, vol.100, pp.2026-2046, 2004.

K. Dm, . Schubert-mm, S. Elting-ls, E. St, R. Jb et al., Updated Clinical Practice Guidelines for the Prevention and Treatment of Mucositis, Cancer, vol.109, pp.820-831, 2007.

L. K. , G. P. , G. T. Mcdonnnell, P. , T. R. et al., A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation, Bone Marrow Transplant, vol.37, pp.1031-1035, 2006.

S. Mm, F. Jc, N. , M. F. , L. M. et al., Effects of low-energy laser on oral mucositis: a phase I:II pilot study, Cancer Res Wkly, vol.7, p.14, 1994.

M. A. , H. M. , I. M. Shamshiri-ar, H. A. , and J. Mr, The effect of zinc sulfate in the prevention of high-dose chemotherapy-induced mucositis: a double-blind randomized, placebocontrolled study, Hematol Oncol, 2011.

H. Caphosol, solution électrolytique pour bain de bouche; Avis défavorable au remboursement dans la prévention et le traitement de la mucite secondaire à une radiothérapie ou à une chimiothérapie à haute dose, 2010.